Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657024 | 1.00 | HIF1A (0.61) | HIF1ASLC29A1 | |
| SCHEMBL13265483 | 1.00 | HIF1A (0.61) | HIF1ASLC29A1 | |
| SCHEMBL13265479 | 0.95 | HIF1A (0.65) | HIF1ASLC29A1 | |
| SCHEMBL13265485 | 0.86 | DNPH1 (0.62) | HIF1ASLC29A1 | |
| SCHEMBL5982949 | 0.84 | HIF1A (0.71) | HIF1A | |
| SCHEMBL5982940 | 0.84 | HIF1A (0.71) | HIF1A | |
| SCHEMBL13265431 | 0.84 | HIF1A (0.71) | HIF1A | |
| SCHEMBL13265444 | 0.83 | HIF1A (0.69) | HIF1A | |
| SCHEMBL13239681 | 0.82 | HPGD (0.43) | HIF1ASLC29A1 | |
| SCHEMBL15165603 | 0.82 | HPGD (0.43) | HIF1ASLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117343990-B | Method and kit for determining target polynucleotide and probe set | 牛津纳米孔科技公开有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-112703256-B | Method for determining polymer sequences | 牛津纳米孔科技公开有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-117343990-A | Method and kit for determining target polynucleotide and probe set | 牛津纳米孔科技公开有限公司 | 2024-01-05 | — | — | CN | disclosed |
| WO-2023147565-A2 | METHODS AND SYSTEMS FOR HIGH-THROUGHPUT MOLECULAR ANALYSIS | Opentrons LabWorks Inc. (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20230046363-A1 | METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-02-16 | — | — | US | disclosed |
| CN-115491373-A | CRISPR/CAS related methods and compositions for treating herpes simplex virus | 爱迪塔斯医药公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-109312338-B | CRISPR/CAS related methods and compositions for treating herpes simplex virus | 爱迪塔斯医药公司 | 2022-09-27 | — | — | CN | disclosed |
| US-11390884-B2 | Optimized CRISPR/cas9 systems and methods for gene editing in stem cells | EDITAS MEDICINE, INC. (US) | 2022-07-19 | — | — | US | disclosed |
| CN-107690480-B | Evaluation of CAS9 molecule/guide RNA molecule complexes | 爱迪塔斯医药公司 | 2022-03-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11390884-B2 | Optimized CRISPR/cas9 systems and methods for gene editing in stem cells | ZFX, DCLRE1B, APOBEC3C | HIF1A 1394/4885SLC29A1 2238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.